The evidence in support of genetic-based dosing of coumarin anticoagulant drugs such as warfarin is mixed at best, based on the results of three studies published in The New England Journal of Medicin
Device Transactions Device companies raised a total of $801 million in 2012’s third quarter, an 18% drop from Q2’s $977 million. Late-stage venture rounds tied debt as the most lucrative financing veh
IN VITRO DIAGNOSTICS Mergers & Acquisitions ERBA Diagnostics Mannheim GMBH ERBA Diagnostics Inc. Escalon Medical Corp. Drew Scientific Inc. JAS Diagnostics Inc. ERBA Diagnostics Inc. , which is maj